Bradley P. Dixon

Pediatric Nephrology
13123 E 16th Ave
Aurora, CO 80045

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 62 publications

Blood Pressure Control in Adolescents With CKD and Risk of Kidney Failure in Young Adulthood.

Blood Pressure Control in Adolescents With CKD and Risk of Kidney Failure in Young Adulthood.

Journal: Kidney medicine
Published: June 03, 2026

Contemporary Treatment Responses of Recurrent Focal Segmental Glomerulosclerosis or Steroid Resistant Nephrotic Syndrome in Children after Kidney Transplantation: Phase 2 of a Multicenter Electronic Health Record Data Analysis.

Contemporary Treatment Responses of Recurrent Focal Segmental Glomerulosclerosis or Steroid Resistant Nephrotic Syndrome in Children after Kidney Transplantation: Phase 2 of a Multicenter Electronic Health Record Data Analysis.

Journal: Research square
Published: May 04, 2026

Comparative Effectiveness of Antihypertensive Medications in Children With Chronic Kidney Disease.

Comparative Effectiveness of Antihypertensive Medications in Children With Chronic Kidney Disease.

Journal: JAMA pediatrics
Published: March 16, 2026

Pegcetacoplan Versus Iptacopan for the Treatment of Patients with C3 Glomerulopathy: Indirect Treatment Comparisons.

Pegcetacoplan Versus Iptacopan for the Treatment of Patients with C3 Glomerulopathy: Indirect Treatment Comparisons.

Journal: Advances in therapy
Published: February 17, 2026

Biomarkers in the Management of Complement-Mediated Kidney Diseases in the Era of Complement Therapeutics.

Biomarkers in the Management of Complement-Mediated Kidney Diseases in the Era of Complement Therapeutics.

Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: December 17, 2025

Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN.

Trial of Pegcetacoplan in C3 Glomerulopathy and Immune-Complex MPGN.

Journal: The New England journal of medicine
Published: December 03, 2025

Pegcetacoplan for Adolescents with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative GN: Phase 3 VALIANT Subgroup Analysis.

Pegcetacoplan for Adolescents with C3 Glomerulopathy or Primary Immune Complex Membranoproliferative GN: Phase 3 VALIANT Subgroup Analysis.

Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: November 10, 2025

Using a multi-institutional pediatric learning health system to characterize induction therapy for incident lupus nephritis in children.

Using a multi-institutional pediatric learning health system to characterize induction therapy for incident lupus nephritis in children.

Journal: Pediatric nephrology (Berlin, Germany)
Published: May 30, 2025

Hypertension, proteinuria, and RAAS inhibition use in children with systemic lupus erythematosus: Data from a multi-institutional pediatric learning health system.

Hypertension, proteinuria, and RAAS inhibition use in children with systemic lupus erythematosus: Data from a multi-institutional pediatric learning health system.

Journal: Lupus
Published: May 20, 2025

Natural History of C3 Glomerulopathy and Immune Complex-Associated Membranoproliferative Glomerulonephritis in Children.

Natural History of C3 Glomerulopathy and Immune Complex-Associated Membranoproliferative Glomerulonephritis in Children.

Journal: Clinical journal of the American Society of Nephrology : CJASN
Published: April 14, 2025

Kidney Function Following COVID-19 in Children and Adolescents.

Kidney Function Following COVID-19 in Children and Adolescents.

Journal: JAMA network open
Published: April 11, 2025

Assessing C3 glomerulopathy outcomes in children: how concerned should we be?

Assessing C3 glomerulopathy outcomes in children: how concerned should we be?

Journal: Pediatric nephrology (Berlin, Germany)
Published: February 17, 2025
Showing 1-12 of 62

Last Updated: 09/26/2026